Predictions
Sunworks Inc.
Start price
Target price
Perf. (%)
€19.80
25.01.21
25.01.21
€25.00
25.01.22
25.01.22
-88.49%
17.01.22
17.01.22
Revenue growth >5% per year expected
Top 10 in its market
Small cyclical dependencies
Known brand
Royal Helium Ltd.
Start price
Target price
Perf. (%)
€0.50
24.01.21
24.01.21
€1.00
24.01.22
24.01.22
-53.12%
25.01.22
25.01.22
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Americas Gold & Silver Corp.
Start price
Target price
Perf. (%)
€2.19
23.01.21
23.01.21
-
23.01.22
23.01.22
-68.55%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Revenue growth >5% per year expected
Innovative
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.31
23.01.21
23.01.21
€6.00
23.01.22
23.01.22
33.11%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Ynvisible Interactive
Start price
Target price
Perf. (%)
€1.19
23.01.21
23.01.21
€10.00
23.01.22
23.01.22
-86.60%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
STS Group AG
Start price
Target price
Perf. (%)
€6.98
23.01.21
23.01.21
-
23.01.22
23.01.22
16.33%
24.01.22
24.01.22
Medium risks for its business
Some uniques
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Bilibili Inc.
Start price
Target price
Perf. (%)
€102.00
18.01.21
18.01.21
€80.00
18.04.21
18.04.21
-15.49%
18.04.21
18.04.21
High valuation
Very low/no dividend yield expected
Higher risks for its business
Wirecard AG ADR
Start price
Target price
Perf. (%)
€0.21
17.01.21
17.01.21
€100.00
17.01.22
17.01.22
-90.38%
18.01.22
18.01.22
Could be very worthwhile Investment >20% year
Well known brand
Everfuel A/S
Start price
Target price
Perf. (%)
€14.04
13.01.21
13.01.21
€6.00
13.01.22
13.01.22
-68.83%
14.01.22
14.01.22
Very Future proof/growth oriented business model
Probably not worthwhile Investment
Very low/no dividend yield expected
Nicheplayer
Reconnaissance Energy Afri.ltd
Start price
Target price
Perf. (%)
€1.69
12.01.21
12.01.21
-
12.01.22
12.01.22
214.20%
13.01.22
13.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Aileron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.50
11.01.21
11.01.21
-
11.01.22
11.01.22
-6.67%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Good culture
Innovative
Growths slower than the competition
Sunworks Inc.
Start price
Target price
Perf. (%)
€6.30
11.01.21
11.01.21
€17.00
11.01.22
11.01.22
139.68%
22.01.21
22.01.21
Revenue growth >5% per year expected
Top 10 in its market
Small cyclical dependencies
Known brand
Comtec Solar Systems Group Ltd
Start price
Target price
Perf. (%)
€0.028
06.01.21
06.01.21
-
06.01.22
06.01.22
58.18%
25.10.21
25.10.21
Medmen Enterprises Inc.
Start price
Target price
Perf. (%)
€0.12
05.01.21
05.01.21
€8.00
05.01.22
05.01.22
24.70%
06.01.22
06.01.22
Capable Management
Known brand
Future proof or reliable business model
Appen Ltd.
Start price
Target price
Perf. (%)
€16.20
01.01.21
01.01.21
€23.00
01.01.22
01.01.22
-63.58%
24.09.21
24.09.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
BioVaxys Technology Corp.
Start price
Target price
Perf. (%)
€0.13
30.12.20
30.12.20
€5.00
30.12.21
30.12.21
9.92%
31.12.21
31.12.21
Could be very worthwhile Investment >20% year
Strong uniques
Very Future proof/growth oriented business model
Leading role in innovation
Rainforest Resources Inc.
Start price
Target price
Perf. (%)
€1.61
28.12.20
28.12.20
€1.00
-6.21%
29.12.20
29.12.20
Risky Investment
Business model of the past or high risk
Little known brand
Westwing Group AG
Start price
Target price
Perf. (%)
€31.42
25.12.20
25.12.20
€48.60
25.12.21
25.12.21
-29.59%
26.12.21
26.12.21
Could be worthwhile Investment >10% per year
Ocugen Inc.
Start price
Target price
Perf. (%)
€0.60
22.12.20
22.12.20
-
22.12.21
22.12.21
1408.67%
07.11.21
07.11.21
Probably not worthwhile Investment
Equillium Inc.
Start price
Target price
Perf. (%)
€3.82
21.12.20
21.12.20
€6.00
21.12.21
21.12.21
3.14%
20.12.21
20.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
Christina Lake Cannabis Corp.
Start price
Target price
Perf. (%)
€0.49
19.12.20
19.12.20
€1.00
19.12.21
19.12.21
-65.57%
20.12.21
20.12.21
Could be very worthwhile Investment >20% year
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€2.74
18.12.20
18.12.20
-
18.12.21
18.12.21
-45.99%
19.12.21
19.12.21
Probably not worthwhile Investment